Breakthrough system set to revolutionize molecular diagnostics by enabling 24/7 sample-to-result PCR testing with no human intervention....
Breakthrough technology aims to transform hematology diagnostics by combining full-field imaging and AI-driven analysis for faster, more accurate results....
Collaboration aims to develop next-generation endoluminal robotic platforms for enhanced precision and minimally invasive interventions in gastrointestinal care....
Simplified Process Aims to Boost Participation in Colorectal Cancer Screening and Improve Early Detection Rates...
Clinical research highlights the potential of Hyperfine’s portable brain imaging system to improve early diagnosis and expand access to neuroimaging in underserved dementia populations....
How high-quality, integrated datasets are transforming drug repurposing from opportunistic discovery to systematic innovation in therapeutic development. ...
Landmark integration of in vitro organ-on-a-chip and computational modeling marks a pivotal advancement in disease simulation, drug testing, and personalized medicine....
New patent strengthens global IP portfolio for noninvasive lung cancer detection platform, expanding bioAffinity’s reach into international markets ...
Danish multicenter study confirms clinical utility of genomic test in identifying low-risk stage I–II melanoma patients, advancing precision in surgical decision-making ...
The NMPA approval of the ZEISS CLARUS 700 represents a major leap forward in ultra-widefield retinal imaging, offering high-resolution, true color visualization to support early detection and management of complex eye diseases across China....
